Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study

ConclusionCRT should be considered for cT3N0 patients, but its timing (neoadjuvant vs. adjuvant) seems not to affect the disease-free survival in the present cohort of patients.

http://link.springer.com/10.1007/s00384-019-03446-4

Source: International Journal of Colorectal Disease - November 17, 2019 Category: Gastroenterology Source Type: research